In spite of the increase in longevity in the past century, studies of mortality patterns in elderly populations are scarce. We investigated cardiovascular and all-cause mortality patterns in age-group 75-84 years in Europe in the period 1970-1996. Methods Mortality data for the age-group 75-84 years were obtained from WHO and standardized according to the old European population standard. Tables were produced showing mortality rates per country around the year 1995 and trends were calculated over the period 1970-1996 using linear regression analysis.
Introduction
The span of human life has increased considerably during the past century. As a consequence of the almost universal prolongation of life expectancy the number of subjects of both sexes surviving until the age of 85 years is increasing. However, relatively little attention has been paid to the evolution of mortality rates in older age groups. Recently the evolution of cardiovascular mortality in Europe in the age-group 45-74 years has been studied extensively [1] [2] [3] . It confirmed the marked decline of mortality in Western Europe and the occurrence of a major increase in Eastern Europe. The reason for the lack of interest in the mortality rates in the older age-groups has essentially been two-fold: the lower importance of this age group as a percentage of the total population and the concept that it would be difficult to influence mortality at higher ages since the determinants of mortality at the population level would have already been operative over many decades. It thus seems appropriate to pay special attention to the evolution of all-cause and cardiovascular mortality in the agegroup 75-84 years, which is becoming of growing importance. Since the evolution of mortality in old age and the causes of mortality may differ between various populations, mortality rates obtained from different parts of the world will be used for comparison.
Methods
The mortality data were obtained from a special WHO tape, providing mortality data in 5-year age-groups up to the age of 84 years. This is an extension of the data provided by the World Health Statistics Annual [4] . The data for the age-group 75-84 years were standardized according to the old European standard population. Use was made of data concerning all causes (ICD9 01-E99), total cardiovascular diseases (ICD9 25-30), ischaemic heart disease (ICD9 27), stroke (ICD9 29) and a group called 'remainder' (all causes-total cardiovascular diseases) to which cancer mortality (ICD9 08-14) is an important contributor [5] . Sex-specific analyses were performed. The evolution of mortality was studied from 1970 until the latest available year (LAY), mostly around 1996. The year 1970 was chosen as a starting point since ICD-8 was introduced in 1969. Moreover, in many countries the decrease in mortality started around 1970. The data from most Eastern European countries became available only after 1985. For comparative purposes, some data for the period 1955-1969 are 
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presented. For this later period, the corresponding codes for total cardiovascular diseases (A70, A79-A86 and A080-A088) and for cancer (A044-A059 and A045-A060) of the ICD-7 and ICD-8 classifications were used. Since only broad groups of diseases were studied, the possible influences of ICD classification changes are minimal. Data for 35 countries were analysed. The countries were also aggregated into five groups according to geographical location in order to facilitate the comparison of data obtained in different parts of the world (see legend to Fig. 1) .
The annual percentage decline in mortality rates was obtained by linear regression analysis. The intercept (constant) of the regression is the calculated mortality in 1970. Both the constant and the slope are given in actual numbers.
For the construction of the figures the mean mortality rate for all countries in each group was calculated. An equal weight was thus allocated to each country. This means that a country like Belgium or Norway carries a weight equal to the U.S.A. or Japan, countries with much larger populations. It demonstrates, however, to a more accurate extent the similarity or discrepancy of the changes going on worldwide. This study does not concern absolute number of deaths at the global population level as it only considers mortality rates/100 000/year.
In order to incorporate Germany, which until 1990 consisted of two countries, the FRG and GDR, the data were combined for the period 1970-LAY with a ratio of 3:4 for the FRG and 1:4 for the GDR, roughly equivalent to the population distribution of both countries.
Results
In Table 1 the mean mortality rates of the last 3 available years, mostly from the period 1994-1997 are given for all-causes, total cardiovascular diseases and 'remainder' mortality. The table is ranked according to the magnitude of the male mortality rate for all causes. For all three causes of mortality, important differences between countries are evident. Mortality rates are always substantially lower in women, but the differences between the highest and lowest mortality rates are higher in women compared to men. In most Western countries, total cardiovascular diseases mortality is less or close to 50% of all-cause mortality, while in Eastern European countries this percentage is much higher, up to 73% in Bulgaria. An identical significant inverse correlation exists in both sexes (r= 0·46, P<0·01) between the remainder and total cardiovascular diseases mortality rates. In men, total cardiovascular diseases mortality is responsible for 54% of all causes mortality and in women for 60% when the total group of 35 countries is considered.
In Tables 2 and 3 the all causes, total cardiovascular diseases and remainder mortality changes, as obtained by linear regression equations are given for both men and women, respectively, for the period 1970-LAY. Countries are grouped by world regions and then ranked according to the magnitude of the estimated all-cause mortality. Differences in the number of available years of observation exist between countries. During the period 1970-LAY, all-cause mortality decreased in 32 countries in men and in 33 in women out of 35 countries. In most of the countries the decreases were highly significant but the increases were not. This is due to the fact that the increases occurred predominantly in the period 1987-1993 and were followed by significant decreases. The smallest decreases and all increases occurred in the countries of Eastern Europe. Most of the Trends in cardiovascular mortality 387 changes in all-cause mortality rates are due to changes in total cardiovascular diseases mortality, except in Greece and several Eastern European countries. For ischaemic heart disease and stroke mortality, important changes were also evident during the period 1970-LAY (Tables 4 and 5 ). Regarding ischaemic heart disease mortality the division between Eastern and Western Europe is less clear than for all-cause mortality. High increases in ischaemic heart disease mortality occurred in several Eastern European countries. Mortality from ischaemic heart disease has declined, especially in the U.S.A. in both sexes, where it more than halved during the last 25 years; in Japan such mortality has always been low and moderately declining. Stroke mortality is declining worldwide, except in Eastern Europe. The decline has been most pronounced in Japan, but this decline has almost stopped during the last 5 years in both sexes. Mortality from stroke is also leveling off in other countries, especially in the U.S.A. The division in Europe is, however, again apparent for stroke mortality in both sexes with astonishingly high decreases in many Western countries but increases in several Eastern European countries. In general, the initial levels of stroke mortality were lower in Eastern European countries in 1970. Most of the decline in total cardiovascular diseases is due to changes in stroke, except in Oceania, North America, several Eastern European countries, Scotland, Netherlands, Denmark and Sweden.
In general, an important decrease in remainder mortality occurred over the period of 25 years, with the exception of North America where it is increasing, especially in women. The remainder mortality is lowest in Eastern European countries. Cancer is an important component of the remainder mortality and its rates increased over the period 1970-LAY in 31 out of 35 Legend see footnote in Table 2 countries in men and in 25 out of 35 countries in women (values not given). The changes were nearly always highly significant in men and predominantly significant in women. In Western European populations in the age-group 75-84 years, cancer mortality increased between 1955 and 1994 in men from about 1540/100 000/ year to 2120/100 000/year (+37%). No significant change occurred between 1983 and 1994. In women, total cancer mortality decreased over the same period from 1080/100 000/year to 1050/100 000/year ( 3%), with no significant changes between 1979 and 1994. Notwithstanding the marked differences in mortality levels between the sexes, they remain highly correlated. The slope of the decline, the percentual decline and the significance level of the decline in the period 1970-LAY between the sexes are also highly significantly correlated (Table 6 ).
In some countries, a low correlation coefficient of mortality rates over the period considered was obtained (data not shown). This could be mostly due to nonlinear changes as a result of both increases and decreases or acceleration of the occurring changes in mortality rates over the period considered. This occurred predominantly in Eastern European countries.
The spectacular worldwide decrease in all-cause mortality rates in the age-group 75-84 years and the geographical differences for both sexes are evident from Figs 1 and 2. The most important decline occurred in Japan, in both sexes and with the exception of Eastern Europe the least decline was observed in the Western European countries.
The changes in total cardiovascular diseases mortality run almost in parallel with those of all-cause mortality, in both sexes (Figs 3 and 4) . Strikingly different patterns Legend see footnote in Table 2 Trends in cardiovascular mortality 389 in the evolution of the remainder mortality were observed, especially in North America. In both sexes, the differences between regions for remainder mortality are lower in 1997 compared to 1970 (Figs 5 and 6 ). When Europe is considered, the decreases in Western Europe in the period 1955-1994 are spectacular. However, while the decline in women was linear over the whole period, in men it was more pronounced during the later half of the period. From 1970 to 1994, all-cause mortality rates decreased by 25% in men and by 38% in women. For total cardiovascular diseases mortality rates, the decrease was 34% and 46%, respectively. The decrease in both all-cause mortality rates and total cardiovascular mortality rates accelerated after 1975. The decline in stroke mortality rate is especially prominent during the last 25 years (Fig. 7) . The decline in ischaemic heart disease mortality is somewhat more 4540  92·7#  2·04  1151  22·0#  1·91  1673  44·8#  2·68  27 Sweden  4400  81·2#  1·85  2722  65·7#  2·41  1048  17·1#  1·63  25 Switzerland  4374  103·6#  2·37  824  1·1  0·14  1341  38·6#  2·88  26 Norway  4123  72·4#  1·76  1710  24·8#  1·45  1558  36·0#  2·31  27 Denmark  4090  67·9#  1·66  2433  49·1#  2·02  990  15·1#  1·53  28 Netherlands  3923  76·0#  1·94  1581  31·8#  2·01  1205  25·3#  2·10  28 Greece  3472  9·2  0·26  515  4·8**  0·93  1846  8·7**  0·47  27 France  3296  76·2#  2·31  634  7·9#  1·24  1328  38·3#  2·89  26 Iceland  3242  45·5 ‡  1·40  1625  15·2  0·94  1137  27·5 ‡  2·42   OCE  26 Australia  5308  129·5#  2·44  2411  48·3#  2·00  1809  53·5#  2·96  27 New Zealand  4691  87·9#  1·87  2170  29·4#  1·35  1656  40·6#  2·45   NA  28 USA  4307  91·2#  2·12  2646  69·2#  2·62  1057  28·9#  2·74  28 Canada  3941  86·9#  2·21  2266  52·8#  2·33  1002  25·2#  2·52   JAP  28 Japan  4586  126·6#  2·76  556  9·7#  1·75  2737  89·6#  3·27 Legend see footnote in Table 2 (Fig. 8 ). All these changes run in parallel in both sexes but at a lower level in women.
Discussion
The span of human life has increased considerably, not only during the first half but even more markedly during the second half of the past century. It is predicted that, based on the data of seven industrialized countries, the decline may continue in the 21st century at a remarkably constant pace [1] . In order, however, to make more meaningful predictions on the evolution of life expectancy the causes of both the declines and increases in mortality rates observed in different countries should be better understood. Much will depend on our growing understanding of the importance of stopping smoking, of a healthy diet and of a beneficial socio-economic development. Moreover, strong evidence points to the existence of a maximum life expectancy in humans [2] . Due to the general increase in life expectancy and a decreasing birth rate, the age-group 75-84 years is of growing importance and in some Western populations is the fastest growing segment of the population. This warrants the extension of the study of mortality to younger age-groups [3] [4] [5] [6] , to the age-group 75-84 years. Moreover, the predominating decline, often spectacular, in mortality rates in this older age-group demonstrates that a passive attitude is not justified. This increase in the number of older people has also important socioeconomic consequences e.g. pensions, housing, expenses for medical care, institutional care for older people.
One supplementary problem is the influence of age on mortality. Gompertz equations [7] show a linear relationship between log mortality rate and age, in the age range 35-84 years in both sexes [8, 9] . This means that the mortality rates at older ages can be derived from 
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the mortality rates at younger ages. The slope of the equation is, however, modulated by environmental factors [8] . In countries with high mortality rates at younger ages, those who survive until age 75 years are undoubtedly a selection of the healthiest and most disease-resistant individuals in a given population. This selective survival may explain why all-cause mortality in Hungary in men is declining in the age-group 75-84 years, but increasing significantly in the younger age-groups. It also can explain the fact that Blacks in the U.S.A. have a markedly higher mortality rate than Whites but a lower mortality rate above the age of 87 years [10] . The evidence pointing to a maximum life span would result in a compression of mortality and morbidity at older ages [11, 12] . The mechanisms by which age independently influences mortality are thus complex and the problem remains to a large extent unsolved.
During the period 1970-LAY, all-cause mortality decreased in nearly all countries in both men and women, with the most marked decrease occurring in Japan and the highest increase occurring in Ukraine, for both sexes. Of all Western countries Denmark, Iceland and the Netherlands show the lowest percentual decrease in men, and Denmark, Iceland and Greece in women. The high decrease in Germany for men is partly due to the inclusion of the former GDR in the data set, which explains why Germany had the highest calculated mortality rate in 1970.
During the period 1955-1969, however, (data not shown) the all-cause mortality rate decreased in men in 16 countries and increased in 13, out of a total of 29 countries. In women, in contrast, the decline was almost universal (in 27 out of 29 countries). The increase in men also occurred in several Western populations at a time of great socio-economic progress. The specific causes of these increases during that period have never been fully investigated.
Regarding total cardiovascular diseases mortality rates the picture is very similar: during the period 1955-1969 an increase in male mortality occurred in a majority of countries but in a minority of countries for female mortality. In the period 1970-LAY, mortality decreased in a majority of countries with the exception of several Eastern European countries and Greece (Table 3) . Both for all-cause and total cardiovascular diseases mortality the percentual decreases were usually higher in women than in men, notwithstanding a markedly lower level of mortality. These decreases in mortality rates occurred notwithstanding a progressive slight increase in the mean age of the age-group 75-84 years, due to the lowering of the age-specific mortality rates.
Both during the period 1955-1969 and 1970-LAY in the age-group 45-74 years, the decreases in mortality rates for all causes and total cardiovascular diseases were more important in women than in men, resulting in an increase of the sex ratio (M/F) of mortality [13] . This increase in sex ratio over the last 40 years is also present in the age-group 75-84 years, resulting in an increase of female predominance in that age-group. Highly significant correlations exist in the mortality rates between sexes. This indicates that the same causal factors are operative in both sexes, but at a lower level in women. The lowest correlation is found for changes in cancer mortality, presumably largely due to differences in smoking levels between the sexes.
Ischaemic heart disease and stroke mortality are the major components of total cardiovascular diseases mortality. The ischaemic heart disease mortality rate declined in most countries for men and in almost all 
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for women during the period 1970-LAY. In men the increase, when present, occurred not only in Eastern Europe but also in Switzerland and Greece. A similar picture emerges for stroke mortality, but here the increases are limited to Eastern European countries [14, 15] . Only one mortality rate is free from certifying or coding biases: all-cause mortality. This is especially true at older ages where the precision of the cause-specific mortality rates can be questioned. Autopsy rates are also low in older people. For this reason only broad groups of causes of mortality rates are considered in this study. Regarding ischaemic heart disease mortality, some caution should be expressed concerning the correctness of the diagnosis.
All-cause and total cardiovascular diseases mortality is very high in Eastern Europe [16] . Nevertheless, a small tendency to decrease can be observed over the limited observation period of 11 years. A significant increase was observed in total cardiovascular diseases mortality in Yugoslavia. This is compatible with the large increase in serum cholesterol and blood pressure in the Serbian cohorts of the Seven Countries Study observed in the period 1962-1989 [17] . Another remarkable feature is the increase of cardiovascular mortality in the elderly in Greece. This is in contrast to the strong decreasing trend in the other Southern European countries. Longitudinal data of the Cretan cohort of the Seven Countries Study showed a substantial increase in serum cholesterol, blood pressure and body mass index between 1960 and 1991 [18] . The remainder mortality is also declining in most parts of the world, except in North America, in spite of increasing rates of cancer mortality. The decline in remainder mortality shows that the decrease in cardiovascular disease mortality cannot be explained by a misclassification into non-cardiovascular mortality. The low remainder mortality in Eastern Europe, including its low cancer mortality (data not shown), remains unexplained and raises the question of the reliability of the diagnostic criteria in this part of the world and these data need to be validated.
In a great majority of countries, cancer mortality increased between 1970-LAY in both sexes. The only real decrease in cancer mortality occurred in men in the U.S.A. and Canada, but only since 1989. These changes in cancer mortality rates are highly related to the level of smoking. Smoking cessation should remain a major goal for preventive medicine, both for cardiovascular disease and cancer. When only Western European countries are considered, the decrease in all-cause mortality since 1955 is impressive, especially since about 1975. The exception is cancer mortality, which is only recently levelling off in both sexes. This levelling off could be due to changes in smoking behaviour at the population level.
A discussion of the factors responsible for the ongoing changes in all-cause and total cardiovascular diseases mortality in Europe and worldwide is beyond the scope of this study. A strong case can be made for the predominance of nutritional, smoking and socioeconomic factors as determinants of mortality [8, [19] [20] [21] [22] [23] .
Other important factors are alcohol [24] , the level of physical activity, psycho-social factors and obesity [25] , type of medical care, genetics, etc. The relative level of importance of those factors may vary among different populations. Thus, the high mortality in Eastern Europe has been attributed to high levels of saturated fat intake [9] , high levels of alcohol drinking, violence and pollution [16] . It is questionable, with the possible exception of nutrition, whether these factors are as important in the age-group 75-84 years as in younger age-groups. 
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In conclusion, major changes occurred in subjects aged 75-84 years, in both sexes, in all-causes, total cardiovascular diseases and remainder (mostly cancer) mortality. Declines in mortality, often very substantial, predominated. The decline in all-cause mortality over the period considered is almost exclusively due to a decline in total cardiovascular disease mortality, which in turn is mostly due to changes in stroke. Total cardiovascular mortality, however, remains extremely high in Eastern European countries. The causes of the changes in mortality must be environmental since a significant change in the genetic constitution of a given population over a period of only 45 years is impossible. Changes in lifestyle, especially in nutritional habits, smoking, socio-economic status and in the accessibility of medical care, offer the most plausible explanation. A passive attitude concerning the health problems at older age is not warranted. 
